Agreements
* Aurora Biosciences (San Diego, California) has entered into an agreement with the Parke-Davis Research Division (Ann Arbor, Michigan) of Warner-Lambert to develop an automated master compound storage system for chemical and biological compounds. Warner-Lambert will pay Aurora more than $9 million over the next 15 months. The automated master compound storage system is a modular storage assemblage. * Bayer (Leverkusen, Germany) has signed a non-exclusive licensing agreement with Metra Biosystems (Mountain View, California) to market the Pyrilinks-D deoxy-pridinoline (Dpd) bone resorbtion assay worldwide, except Japan, for use on the Bayer Immuno 1 analyzer. Chiron Diagnostics and DPC already offer the Pyrilinks-D test on their systems. * BioResearch Ireland (BRI; Dublin, Ireland) has con-cluded an agreement with Eurospital (Trieste, Italy) for a worldwide exclusive license for BRI’s patented coeliac dis-ease diagnostic assay developed in collaboration between BRI and researchers at St. James Hospital (Dublin). Eurospital already markets a range of dietary intolerance and other autoimmune tests, and will carry out evaluations at a number of European locations. * Chronimed (Minneapolis, Minnesota) said it will distribute the Lasette laser finger perforator produced by Cell Robotics (Albuquerque, New Mexico) under an agree-ment described by Cell Robotics as a two-year, multi-mil-lion- dollar minimum purchase. Besides distributing the Lasette and accessories worldwide, Chronimed will assume existing international distribution agreements with companies in China and Japan. The company also will make a staged purchase of $600,000 of Cell Robotics’ com-mon stock based on certain milestones. * Delsys Pharmaceutical (Princeton, New Jersey) has formed an agreement with Glaxo Wellcome (Research Tri-angle Park, North Carolina) to evaluate the use of Delsys’ dry powder handling technology in the Glaxo Wellcome dry powder inhaler development program. Delsys’ tech-nologies are derived from the electrostatic dry powder han-dling processes pioneered by the Sarnoff Corp., including a highly controlled electrostatic powder deposition process which permits the active ingredient of a drug to be deposit-ed in very precise quantities at high speed onto a variety of surfaces. * Desmos (San Diego, California) renewed its relation-ship with Baxter Healthcare (Deerfield, Illinois) to explore approaches to sealing for improving the biocompatibility of percutaneous implants used in renal therapy. The new bio-coating being developed will create a biological seal around the entry site, reducing infections and implant instability. * E. Merck (Darmstadt, Germany) is collaborating with Whatman International (Maidstone, United Kingdom) to distribute through the Europe-wide distribution channels of the Merck Laboratory Division the Whatman line of labora-tory filters, microplates and centrifuge tubes under the joint Whatman-Merck name. * I-Flow (Lake Forest, California) has signed an agree-ment with Smith & Nephew (Mansfield, Massachusetts) for that company to become the exclusive U.S. and Canadi-an distributor for orthopedic surgery applications of I-Flow’s disposable PainBuster infusion pain management kit. Smith & Nephew will purchase a minimum of $2 mil-lion of PainBuster kits from I-Flow in 1998 and enter into a five-year distribution agreement with purchase commit-ments for 1999 and beyond to be negotiated. * Karl Storz Endoscopy-America (KSEA), a sub-sidiary of P. Karl Storz Endoskope GmbH & Co. (Tuttlin-gen, Germany), has formed an agreement with Integrated Medical Systems (IMS; Los Angeles, California) for IMS to repair its customers’ Karl Storz rigid endoscopes in the U.S. IMS is an independent service organization specializ-ing in the repair of surgical and medical equipment. * Physio-Control (Redmond, Washington) has signed an agreement to become the exclusive worldwide distribu-tor of the Biolog 3000 made by Micromedical Industries (Northbrook, Illinois). The monitor provides an initial look at a patient’s ECG and can be used in conjunction with the Physio-Control Lifepak 500 automated external defibrillator. * Retractable Technologies (Dallas, Texas) has formed an agreement to supply safety syringes and blood collection devices to AmeriNet (St. Louis, Missouri), a purchasing group with a combined membership of more than 8,000 health care facilities, about one-third of all of those licensed in the U.S. * Valley Forge Scientific (Oaks, Pennsylvania) and Johnson & Johnson Professional (J&J; Raynham, Massa-chusetts) have extended for one year their distribution agreement covering Valley Forge’s bipolar electrosurgical generators, disposables and products in the neurosurgery field. The extension increases J&J’s 1999 minimum pur-chases of the products to $5 million from $1.1 million. * VidiMedix (Austin, Texas) and American Medical Development (AMD; Lowell, Massachusetts) have formed a strategic alliance in which VidiMedix will offer a variety of AMD medical devices and diagnostic tools as part of its PC-based desktop telemedicine system. AMD is an inter-national supplier of telemedicine peripherals and devices, with product installations at 500 sites in 22 countries. * Vista Medical Technologies (Carlsbad, California) has signed a license agreement with Carl Zeiss (Ober-kochen, Germany) to acquire medical and surgical rights to Zeiss patents, products and technology related to stereo 3-D endoscopy. The agreement gives Vista access to Zeiss technical data, regulatory clearances and product inventories in the field of stereo endoscopy, and Vista will be responsible for supporting the existing installa-tions of Zeiss EndoLive stereo endoscopy systems.
COPYRIGHT 1998 A Thomson Healthcare Company
COPYRIGHT 2004 Gale Group
